Nicole Junkermann, an investor listed in Epstein's contacts and active in health-tech and genomics.
The engine treats her as a figure sitting where biological data meets population management.
She co-invested in and sat on the board of the security firm Carbyne, joined the UK's NHS HealthTech Advisory Board under Matt Hancock in 2018, and through her NJF Capital backed genomics and health-AI companies (Owkin, Cambrian, Gordian); after 2026 revelations she was stripped of a Lancaster professorship and a Royal Marsden trusteeship.
It matters because the engine reads her positions as showing how biological and health data becomes a tool for managing populations.